Last reviewed · How we verify
Enamel Matrix Protein
Enamel Matrix Protein is a Small molecule drug developed by T.C. Dumlupınar Üniversitesi. It is currently FDA-approved. Also known as: emdogain.
At a glance
| Generic name | Enamel Matrix Protein |
|---|---|
| Also known as | emdogain |
| Sponsor | T.C. Dumlupınar Üniversitesi |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Biologicals in Management of Intra-Bony Defects (NA)
- Root Coverage Using ADM and Coronally Positioned Tunnel With or Without Enamel Matrix Derivative (PHASE4)
- Clinical and Radiographic Assessment of Efficacy of Modified Minimally Invasive SurgicalTechnique (M-MIST) Alone and Combined With Enamel Matrix Proteins and Ox-derived Bone Graft in the Treatment of Single Bone Defects Between Teeth. (NA)
- Comparison Between Emdogain and Amniotic Membrane as a Scaffold in Endodontic Regeneration of Immature Anterior Teeth (NA)
- Effectiveness of Hyaluronic Acid (hyaDENT BG® Gel) Compared With Enamel Matrix Proteins (Emdogain®) in the Treatment of Angular Bone Defects in Combination With a Xenograft (Bio-Oss Collagen®) (NA)
- Papilla Preservation Technique in Combination With Tooth Enamel Proteins and Animal Derived Bone Graft in Treating Isolated Bone Defects Between Teeth (PHASE4)
- Evaluation of Self-assembling Peptides Versus Amorphous Calcium Phosphate in the Treatment of White Spot Lesions (NA)
- Colorimetric, Ultra-structural and Elemental Comparison of Dental Enamel Defects
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Enamel Matrix Protein CI brief — competitive landscape report
- Enamel Matrix Protein updates RSS · CI watch RSS
- T.C. Dumlupınar Üniversitesi portfolio CI
Frequently asked questions about Enamel Matrix Protein
What is Enamel Matrix Protein?
Enamel Matrix Protein is a Small molecule drug developed by T.C. Dumlupınar Üniversitesi.
Who makes Enamel Matrix Protein?
Enamel Matrix Protein is developed and marketed by T.C. Dumlupınar Üniversitesi (see full T.C. Dumlupınar Üniversitesi pipeline at /company/t-c-dumlup-nar-niversitesi).
Is Enamel Matrix Protein also known as anything else?
Enamel Matrix Protein is also known as emdogain.
What development phase is Enamel Matrix Protein in?
Enamel Matrix Protein is FDA-approved (marketed).
Related
- Manufacturer: T.C. Dumlupınar Üniversitesi — full pipeline
- Also known as: emdogain
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing